Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Sponsored Video
From Theory To Action: Ensuring Equitable and Individualized Care for Patients with IBD
12/21/2023
In this video, sponsored by Takeda, Ugo Iroku, MD, MHS, delves into the topic of how to ensure the delivery of equitable treatment for all patients with inflammatory bowel disease, irrespective of race, socioeconomic factors, and more.
In this video, sponsored by Takeda, Ugo Iroku, MD, MHS, delves into the topic of how to ensure the delivery of equitable treatment for all patients with inflammatory bowel disease, irrespective of race, socioeconomic factors, and more.
In this video, sponsored by...
12/21/2023
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
Millie Long, MD, on Positioning Therapies for IBD
12/19/2023
Dr Millie Long, one of the cochairs of the AIBD 2023 conference, reviews the challenges of positioning therapies for IBD, cautioning that there are no cut-and-dried answers and clinicians must consider the specific needs of each individual...
Dr Millie Long, one of the cochairs of the AIBD 2023 conference, reviews the challenges of positioning therapies for IBD, cautioning that there are no cut-and-dried answers and clinicians must consider the specific needs of each individual...
Dr Millie Long, one of the...
12/19/2023
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Using Combination Therapy for IBD
12/19/2023
At AIBD 2023, Dr Rubin reviewed the history of combination therapy for inflammatory bowel disease and explored the potential of combining newer biologic and small molecule therapies to address the understand the immunological basis of IBD and...
At AIBD 2023, Dr Rubin reviewed the history of combination therapy for inflammatory bowel disease and explored the potential of combining newer biologic and small molecule therapies to address the understand the immunological basis of IBD and...
At AIBD 2023, Dr Rubin reviewed...
12/19/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Caring for the Older Adult With IBD
12/18/2023
Dr Kochar reviews her talk at AIBD 2023 on how the rapid aging of the population with inflammatory bowel disease will present greater challenges to gastroenterologists when choosing therapies and managing the treatment of patients over 65...
Dr Kochar reviews her talk at AIBD 2023 on how the rapid aging of the population with inflammatory bowel disease will present greater challenges to gastroenterologists when choosing therapies and managing the treatment of patients over 65...
Dr Kochar reviews her talk at...
12/18/2023
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Go Big or Go Small: Corey Siegel, MD, and Miguel Regueiro, MD, Debate Therapies for IBD
12/18/2023
Drs Corey Siegel and Miguel Regueiro recap—with widely divergent viewpoints—their annual debate at the AIBD conference, this time taking on the topic of when to use small molecules vs large in treating patients with IBD. Enjoy!
Drs Corey Siegel and Miguel Regueiro recap—with widely divergent viewpoints—their annual debate at the AIBD conference, this time taking on the topic of when to use small molecules vs large in treating patients with IBD. Enjoy!
Drs Corey Siegel and Miguel...
12/18/2023
Advances in Inflammatory Bowel Disease Network
Stephen Hanauer
Video
Stephen Hanauer, MD, Previews AIBD 2023
12/13/2023
Dr Hanauer, one of the national chairs for Advances in Inflammatory Bowel Diseases 2023, gives a preview of what's coming up at this year's meeting.
Dr Hanauer, one of the national chairs for Advances in Inflammatory Bowel Diseases 2023, gives a preview of what's coming up at this year's meeting.
Dr Hanauer, one of the national...
12/13/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Andres Yarur
Videos
Sherman Emerging Leader Prize 2023: Andres Yarur, MD
12/06/2023
Andres Yarur, MD, received this year’s Sherman Emerging Leader Prize for “Excellence in Crohn’s and Colitis.”
Andres Yarur, MD, received this year’s Sherman Emerging Leader Prize for “Excellence in Crohn’s and Colitis.”
Andres Yarur, MD, received this...
12/06/2023
Advances in Inflammatory Bowel Disease Network
Video
The Sherman Prize 2023: Thaddeus Stappenbeck, MD, PhD
12/04/2023
Dr Thaddeus Stappenbeck has been named one of the Sherman Prize winners for 2023. 
Dr Thaddeus Stappenbeck has been named one of the Sherman Prize winners for 2023. 
Dr Thaddeus Stappenbeck has been...
12/04/2023
Advances in Inflammatory Bowel Disease Network
Corey Siegel
Video
The Sherman Prize 2023: Corey Siegel, MD
12/01/2023
Dr Corey Siegel is named a Sherman Prize winner for 2023.
Dr Corey Siegel is named a Sherman Prize winner for 2023.
Dr Corey Siegel is named a...
12/01/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Miguel Regueiro MD
Video
Miguel Regueiro, MD, on Association of IBD Therapies With Cardiovascular Events
11/15/2023
Dr Regueiro reviews research from Cleveland Clinic that took a closer look at whether biologics and small molecule therapies increase the risk of major cardiovascular events among patients with inflammatory bowel disease.
Dr Regueiro reviews research from Cleveland Clinic that took a closer look at whether biologics and small molecule therapies increase the risk of major cardiovascular events among patients with inflammatory bowel disease.
Dr Regueiro reviews research...
11/15/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Shows Efficacy Among Biologic-Exposed Patients With Crohn’s Disease
09/24/2024
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed...
09/24/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/29/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/29/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Requires Warning Label Change for Thiopurines
08/13/2024
The agency stated that rare cases of intrahepatic cholestasis of pregnancy have been reported among pregnant patients treated with thiopurines for inflammatory bowel disease and systemtic lupus erythematosus.
The agency stated that rare cases of intrahepatic cholestasis of pregnancy have been reported among pregnant patients treated with thiopurines for inflammatory bowel disease and systemtic lupus erythematosus.
The agency stated that rare...
08/13/2024
Advances in Inflammatory Bowel Disease Network
News
MM-SES-CD and SES-CD Threshold Scores and Risk of Disease Progression
08/12/2024
Achieving multiplier Simple Endoscopic Score for Crohn’s Disease
Achieving multiplier Simple Endoscopic Score for Crohn’s Disease
Achieving multiplier Simple...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib vs Tofacitinib for Clinical Remission in Ulcerative Colitis
08/09/2024
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a head-to-head trial of the 2 JAK inhibitors to determine which performed best in achieving steroid-free clinical remission among patients with ulcerative colitis
Investigators conducted a...
08/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jordan Axelrad, MD, on IBD and Malignancy
08/19/2024
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr...
08/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use